Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

Institute of Human Genetics at Heidelberg University Hospital ongoing EEG biomarker study on 15q13.3 CNVs

Firefly’s FDA-cleared BNA platform underpins groundbreaking precision neuroscience study with Heidelberg University - BioTuesdays

Firefly Neuroscience (NASDAQ: AIFF) has announced its continued collaboration with Prof. Christian Schaaf, MD, Director of the Institute of Human Genetics at Heidelberg University Hospital and Chairman of Human Genetics at the Medical Faculty of Heidelburg University, on a groundbreaking study investigating the neurophysiological impact of 15q13.3 copy number variants (CNVs). This builds on prior work between Firefly and Prof. Schaaf, including …